Global life sciences industry players see new opportunities in China, the world's second-largest pharmaceutical market, as the government pushes for innovation for a healthier country.
Saudi Arabian Oil Company (Saudi Aramco), one of the world's top oil exporters, will continue to boost its downstream presence in China, after it formalized plans to build a 300,000-barrel-per-day refining and petrochemical complex along with Norinco Group and Panjin Sincen in Panjin, Northeast China's Liaoning province, in February.
As China's independent refiners, or teapots, see their costs rising thanks to the country's new taxation system and higher crude oil prices, insiders are urging them to shift focus to the high-end market to avoid their margins being further crushed.
Chinese independent refiners, also known as teapots, saw their collective crude oil imports reach 2.72 million barrels per day in January, up 27.7 percent year-on-year, figures from S&P Global Platts reveal.
China's GDP growth is expected to stabilize at 6.2 percent during the first six months of this year, before rebounding in the September-to-December period to reach 6.3 percent whole-year growth, data from the country's leading think tank, the Chinese Academy of Social Sciences (CASS) showed on Monday.
China's leading carmaker BYD launched the world's longest pure electric bus in Shenzhen on Monday, as a precursor to providing comprehensive e-bus production lines in overseas markets.
Market sentiment continued to improve on Monday at the major bourses as a flurry of positive measures announced by the government helped dispel much of the gloom of the last few months.
Foreign capital flows to China are expected to rise from Monday after a portion of the nation's nearly-$13 trillion of onshore bonds were included in a key global index.
As China implements more stringent policies and regulations on the environment, the demand for high-quality iron ore will remain strong in the coming years, which provides companies like Rio Tinto an edge in the country, CEO Jean-Sebastien Jacques said.
In 2013, when he resigned from the prestigious Shanghai East Hospital as director of its vascular surgery department, Zhang Qiang, then 47 years old, was well known for his medical expertise and kindness to patients, earning him the moniker "Doctor Smile".
Although the development of group medical practice faces some problems in China, the government's unwavering efforts to reform the country's healthcare system and robust economic growth will encourage group practices to grow and prosper, an industry insider said.
|
|
|
|
|
|
|
|
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263 Registration Number: 20100000002731 
Raymond Zhou
Op Rana
Berlin Fang
Zhu Yuan
Huang Xiangyang
Chen Weihua
